196 related articles for article (PubMed ID: 1847560)
1. Immunochemical studies on the differential binding properties of two monoclonal antibodies reacting with Tn red cells.
King MJ; Parsons SF; Wu AM; Jones N
Transfusion; 1991 Feb; 31(2):142-9. PubMed ID: 1847560
[TBL] [Abstract][Full Text] [Related]
2. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
Springer GF; Desai PR
Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-GalNAc glycoproteins by breast cancers.
Brooks SA; Leathem AJ
Br J Cancer; 1995 May; 71(5):1033-8. PubMed ID: 7537516
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of sialosyl-Tn (NeuAc alpha 2----6GalNAc alpha 1----O-Ser/Thr) and Tn (GalNAc alpha 1----O-Ser/Thr) blood group antigens on Tn erythrocytes.
Kjeldsen T; Hakomori S; Springer GF; Desai P; Harris T; Clausen H
Vox Sang; 1989; 57(1):81-7. PubMed ID: 2800471
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of erythrocyte populations in Tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen.
Bigbee WL; Langlois RG; Stanker LH; Vanderlaan M; Jensen RH
Cytometry; 1990; 11(2):261-71. PubMed ID: 1690628
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
[TBL] [Abstract][Full Text] [Related]
8. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
[TBL] [Abstract][Full Text] [Related]
9. Application of chemically desialylated and degalactosylated human glycophorin for induction and characterization of anti-Tn monoclonal antibodies.
Duk M; Steuden I; Duś D; Radzikowski C; Lisowska E
Glycoconj J; 1992 Jun; 9(3):148-53. PubMed ID: 1422133
[TBL] [Abstract][Full Text] [Related]
10. Epitopes on sialoglycoprotein alpha: evidence for heterogeneity in the molecule.
Gardner B; Parsons SF; Merry AH; Anstee DJ
Immunology; 1989 Oct; 68(2):283-9. PubMed ID: 2478454
[TBL] [Abstract][Full Text] [Related]
11. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
[TBL] [Abstract][Full Text] [Related]
12. alpha GalNAc is essential for recognition of Exo-1 epithelial antigen by mouse monoclonal antibody Pa-G-14.
Schröder H; Francí C; Egea G; Oriol R; Klingel R; Dippold WG; Real FX
Int J Cancer; 1993 Nov; 55(5):857-64. PubMed ID: 7503962
[TBL] [Abstract][Full Text] [Related]
13. The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies.
Jansson B; Borrebaeck CA
Cancer Immunol Immunother; 1992; 34(5):294-8. PubMed ID: 1540975
[TBL] [Abstract][Full Text] [Related]
14. Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono- and poly-clonal anti-Tn antibodies induced by various immunogens.
Springer GF; Chandrasekaran EV; Desai PR; Tegtmeyer H
Carbohydr Res; 1988 Jul; 178():271-92. PubMed ID: 3056614
[TBL] [Abstract][Full Text] [Related]
15. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
[TBL] [Abstract][Full Text] [Related]
16. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
[TBL] [Abstract][Full Text] [Related]
17. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
18. Identification of the glycosidically bound sialic acid in mucin glycoproteins that reacts as "free sialic acid" in the Warren assay.
Bhavanandan VP; Ringler NJ; Gowda DC
Glycobiology; 1998 Nov; 8(11):1077-86. PubMed ID: 9751794
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody directed to Tn antigen.
Numata Y; Nakada H; Fukui S; Kitagawa H; Ozaki K; Inoue M; Kawasaki T; Funakoshi I; Yamashina I
Biochem Biophys Res Commun; 1990 Aug; 170(3):981-5. PubMed ID: 2390097
[TBL] [Abstract][Full Text] [Related]
20. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
